9.
Accrued Expenses and Other Current Liabilities
Accrued
expenses and other current liabilities consisted of the following:
Schedule
of Accrued Expenses and Other Current Liabilities
| | |
2025 | | |
2024 | |
| | |
December 31, | |
| | |
2025 | | |
2024 | |
| Accrued clinical trial expense | |
$ | 189 | | |
$ | 189 | |
| Accrued professional fees | |
| 488 | | |
| 691 | |
| Accrued wages, bonuses, commissions and vacation | |
| 6,383 | | |
| 5,797 | |
| Accrued interest | |
| — | | |
| 1,798 | |
| Accrued compliance fee | |
| 16,550 | | |
| 10,277 | |
| Accrued vendor expenses | |
| 1,417 | | |
| — | |
| Accrued royalties - Sequence | |
| 3,127 | | |
| — | |
| Acquisition-related contingent consideration | |
| — | | |
| 650 | |
| Vendor settlements | |
| 1,802 | | |
| — | |
| Other current liabilities | |
| 2,618 | | |
| 1,090 | |
| Total
accrued expenses and other current liabilities | |
$ | 32,574 | | |
$ | 20,492 | |
|